comparemela.com

Latest Breaking News On - சார்லஸ் கிறிஸ்டி - Page 1 : comparemela.com

Sindy Asie no 81 : Geographicus Rare Antique Maps

Sindy Asie no 81 : Geographicus Rare Antique Maps
geographicus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geographicus.com Daily Mail and Mail on Sunday newspapers.

EQS-Adhoc: Lonza Group AG: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply

EQS-Adhoc: Lonza Group AG: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply 16-Jul-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug conjugate (ADC) for use against hard-to-treat cancers The deal enables the customer to access commercial-scale production of all elements of its ADC at one site, ensuring security of supply and delivering significant economies of scale. It demonstrates the value of Lonza s Ibex

EQS-Adhoc: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply

EQS-Adhoc: Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply vom 16.07.2021, 07:00 Uhr Bild: pixabay.com Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply 16-Jul-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug conjugate (ADC) for use against hard-to-treat cancers The deal enables the customer to access commercial-scale production of all elements of its ADC at one site, ensuring security of supply and delivering significant economies of scale. It demonstrates the value of Lonza s Ibex

Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody

Lonza Group AG / Key word(s): Agreement/Development of Sales 16-Jul-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug conjugate (ADC) for use against hard-to-treat cancers The deal enables the customer to access commercial-scale production of all elements of its ADC at one site, ensuring security of supply and delivering significant economies of scale. It demonstrates the value of Lonza s Ibex (R) Solutions, providing customers with fast, flexible and tailor-made solutions 

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.